Could the medicalization of psychedelics lead to the next generation of antidepressants?
The biochemist March 28, 2024 Peter J Duggan, S. Walker 1 citation
Humans have used hallucinogenic substances since prehistoric times, often in religious rituals. In the 1960s, the counterculture centered on psychedelics like LSD, leading to their worldwide prohibition under the 1971 UN Convention on Psychotropic Substances, which limited scientific research. Recently, hints that psychedelics may help treat resistant depression and PTSD have spurred efforts to gather clinical data for potential regulatory approval as medical treatments.